Parham Kaboli-Jabbarzadeh

Warsaw, MZ, Poland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications

Next-generation neoantigen mRNA vaccines: Immuno-engineering strategies for precision cancer immunotherapy.

Next-generation neoantigen mRNA vaccines: Immuno-engineering strategies for precision cancer immunotherapy.

Journal: Cellular oncology (Dordrecht, Netherlands)
Published: January 03, 2026

Neoantigen mRNA vaccines and A2A receptor antagonism: A strategy to enhance T cell immunity.

Neoantigen mRNA vaccines and A2A receptor antagonism: A strategy to enhance T cell immunity.

Journal: Human vaccines & immunotherapeutics
Published: January 30, 2025

Reprogramming the breast tumor immune microenvironment: cold-to-hot transition for enhanced immunotherapy.

Reprogramming the breast tumor immune microenvironment: cold-to-hot transition for enhanced immunotherapy.

Journal: Journal of experimental & clinical cancer research : CR
Published: January 16, 2025

Editorial: Glycobiology and glycosylation: deciphering the secrets of glycans in humans and pathogens.

Editorial: Glycobiology and glycosylation: deciphering the secrets of glycans in humans and pathogens.

Journal: Frontiers in immunology
Published: January 13, 2025

c-MET and the immunological landscape of cancer: novel therapeutic strategies for enhanced anti-tumor immunity.

c-MET and the immunological landscape of cancer: novel therapeutic strategies for enhanced anti-tumor immunity.

Journal: Frontiers in immunology
Published: October 06, 2024

The evolution of BRAF-targeted therapies in melanoma: overcoming hurdles and unleashing novel strategies.

The evolution of BRAF-targeted therapies in melanoma: overcoming hurdles and unleashing novel strategies.

Journal: Frontiers in oncology
Published: September 30, 2024

Computational biology and artificial intelligence in mRNA vaccine design for cancer immunotherapy.

Computational biology and artificial intelligence in mRNA vaccine design for cancer immunotherapy.

Journal: Frontiers in cellular and infection microbiology
Published: September 24, 2024

Unraveling the Potential of ALK-Targeted Therapies in Non-Small Cell Lung Cancer: Comprehensive Insights and Future Directions.

Unraveling the Potential of ALK-Targeted Therapies in Non-Small Cell Lung Cancer: Comprehensive Insights and Future Directions.

Journal: Biomedicines
Published: January 06, 2024

Unlocking c-MET: A comprehensive journey into targeted therapies for breast cancer.

Unlocking c-MET: A comprehensive journey into targeted therapies for breast cancer.

Journal: Cancer letters
Published: December 20, 2023

Comprehensive assessment of TECENTRIQ® and OPDIVO®: analyzing immunotherapy indications withdrawn in triple-negative breast cancer and hepatocellular carcinoma.

Comprehensive assessment of TECENTRIQ® and OPDIVO®: analyzing immunotherapy indications withdrawn in triple-negative breast cancer and hepatocellular carcinoma.

Journal: Cancer metastasis reviews
Published: August 17, 2023

Shedding light on triple-negative breast cancer with Trop2-targeted antibody-drug conjugates.

Shedding light on triple-negative breast cancer with Trop2-targeted antibody-drug conjugates.

Journal: American journal of cancer research
Published: March 20, 2022

Pharmacotranscriptomic profiling of resistant triple-negative breast cancer cells treated with lapatinib and berberine shows upregulation of PI3K/Akt signaling under cytotoxic stress.

Pharmacotranscriptomic profiling of resistant triple-negative breast cancer cells treated with lapatinib and berberine shows upregulation of PI3K/Akt signaling under cytotoxic stress.

Journal: Gene
Published: June 06, 2021
Showing 1-12 of 19

Last Updated: 09/26/2026